43.13
price down icon0.88%   -0.425
 
loading

Veracyte Inc Azioni (VCYT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
13.71%
130.16
114.47 115.86 96.84
Cost Of Revenue
15.53%
40.40
34.97 36.85 -
Gross Profit
12.91%
89.77
79.51 79.01 -
Operating Expenses
24.06%
95.04
76.60 66.99 101.50
Benefits Costs and Expenses
20.43%
128.91
107.05 99.01 98.75
Costs And Expenses
24.06%
95.04
76.60 66.99 101.50
Operating Income/Loss
281.40%
-5.268
2.904 12.02 -4.656
Income/Loss From Continuing Operations Before Tax
83.17%
1.25
7.428 16.85 -1.908
Income Tax Expense/Benefit
485.30%
2.23
0.381 1.693 -0.044
Income/Loss From Continuing Operations After Tax
113.91%
-0.98
7.047 15.15 -1.864
Net Income/Loss
113.91%
-0.98
7.047 15.15 -1.864
Preferred Stock Dividends And Other Adjustments
-
- - -
Attributable To Noncontrolling Interest
-
- - -
Basic Average Shares
0.47%
78.39
78.03 77.01 74.76
Diluted Average Shares
2.08%
78.39
80.06 78.46 74.76
Basic Earnings Per Share
111.11%
-0.01
0.09 0.20 -0.02
Diluted Earnings Per Share
111.11%
-0.01
0.09 0.19 -0.02
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - -
diagnostics_research LH
$254.64
price down icon 0.00%
$141.48
price down icon 2.99%
diagnostics_research WAT
$397.60
price up icon 0.26%
diagnostics_research MTD
$1,496.59
price up icon 2.22%
$234.28
price down icon 2.18%
diagnostics_research IQV
$244.94
price up icon 0.71%
Capitalizzazione:     |  Volume (24 ore):